Globally, the interventional radiology products market is witnessing moderate growth due to increasing incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries.

On the other hand, the availability of cost-effective, and the ability to reduce the volume of the product. The high growth potential in the emerging regions of the United States provides opportunities for operating in the interventional radiology products market.

Based on type, the interventional radiology products marketIVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to account for the largest share of the market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of this market segment are the increasing incidence of cancer and rising demand for minimally invasive procedures.

Based on region, the interventional radiology is marketed in North America, Europe, Asia and Rest of the World (RoW). In 2016, North America is expected to dominate the clinical radiology market while Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this geographic segment is attributed to the increasing prevalence of chronic geriatric population in Asia. The market is further driven by factors such as increasing reimbursement for minimally invasive procedures.